These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 19878765)
1. [Recent data in adrenocortical tumorigenesis]. Crand A; Borson-Chazot F; Brue T Ann Endocrinol (Paris); 2009 Sep; 70 Suppl 1():S20-5. PubMed ID: 19878765 [TBL] [Abstract][Full Text] [Related]
2. Insights into the role of genetic alterations in adrenocortical tumorigenesis. Herbet M; Feige JJ; Thomas M Mol Cell Endocrinol; 2009 Mar; 300(1-2):169-74. PubMed ID: 19007854 [TBL] [Abstract][Full Text] [Related]
3. [Pathology of adrenocortical tumors: review and recent data]. Tissier F Ann Endocrinol (Paris); 2009 Jun; 70(3):179-85. PubMed ID: 19298951 [TBL] [Abstract][Full Text] [Related]
5. Advances in understanding the molecular underpinnings of adrenocortical tumors. Nicolson NG; Man J; Carling T Curr Opin Oncol; 2018 Jan; 30(1):16-22. PubMed ID: 29028646 [TBL] [Abstract][Full Text] [Related]
6. [Sporadic adrenocortical tumors: genetics and perspectives for the pathologist]. Tissier F Ann Pathol; 2008 Oct; 28(5):409-16. PubMed ID: 19068395 [TBL] [Abstract][Full Text] [Related]
10. The molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors. Koch CA; Pacak K; Chrousos GP J Clin Endocrinol Metab; 2002 Dec; 87(12):5367-84. PubMed ID: 12466322 [TBL] [Abstract][Full Text] [Related]
11. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Tissier F; Cavard C; Groussin L; Perlemoine K; Fumey G; Hagneré AM; René-Corail F; Jullian E; Gicquel C; Bertagna X; Vacher-Lavenu MC; Perret C; Bertherat J Cancer Res; 2005 Sep; 65(17):7622-7. PubMed ID: 16140927 [TBL] [Abstract][Full Text] [Related]
12. A case report in favor of a multistep adrenocortical tumorigenesis. Bernard MH; Sidhu S; Berger N; Peix JL; Marsh DJ; Robinson BG; Gaston V; Le Bouc Y; Gicquel C J Clin Endocrinol Metab; 2003 Mar; 88(3):998-1001. PubMed ID: 12629075 [TBL] [Abstract][Full Text] [Related]
13. Adrenocortical tumorigenesis. Beuschlein F; Reincke M Ann N Y Acad Sci; 2006 Nov; 1088():319-34. PubMed ID: 17192577 [TBL] [Abstract][Full Text] [Related]
14. Molecular markers and the pathogenesis of adrenocortical cancer. Soon PS; McDonald KL; Robinson BG; Sidhu SB Oncologist; 2008 May; 13(5):548-61. PubMed ID: 18515740 [TBL] [Abstract][Full Text] [Related]
15. Mutations in adrenocortical tumors. Reincke M Horm Metab Res; 1998; 30(6-7):447-55. PubMed ID: 9694578 [TBL] [Abstract][Full Text] [Related]
16. Current update on cytogenetics, taxonomy, diagnosis, and management of adrenocortical carcinoma: what radiologists should know. Ganeshan D; Bhosale P; Kundra V AJR Am J Roentgenol; 2012 Dec; 199(6):1283-93. PubMed ID: 23169720 [TBL] [Abstract][Full Text] [Related]
17. A small adrenocortical carcinoma with aggressive behavior. An evaluation of criteria for malignancy. Gandour MJ; Grizzle WE Arch Pathol Lab Med; 1986 Nov; 110(11):1076-9. PubMed ID: 3778125 [TBL] [Abstract][Full Text] [Related]
18. Classification of adrenal cortical tumors: what limits for the pathological approach? Tissier F Best Pract Res Clin Endocrinol Metab; 2010 Dec; 24(6):877-85. PubMed ID: 21115156 [TBL] [Abstract][Full Text] [Related]
19. Adrenocortical cancer cell line mutational profile reveals aggressive genetic background. Nicolson NG; Korah R; Carling T J Mol Endocrinol; 2019 May; 62(4):179-186. PubMed ID: 30870809 [TBL] [Abstract][Full Text] [Related]